- Home
- ELMD vs GNLX Comparison
ELMD vs GNLX Comparison
Compare ELMD & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELMD | GNLX |
|---|---|---|
| Founded | 1992 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 238.7M | 202.4M |
| IPO Year | 2010 | 2023 |
Fundamental Metrics
Financial Performance| Metric | ELMD | GNLX |
|---|---|---|
| Price | $29.19 | $4.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $36.00 | $19.75 |
| AVG Volume (30 Days) | 56.5K | ★ 111.5K |
| Earning Date | 02-10-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 30.89 | N/A |
| EPS | ★ 0.94 | N/A |
| Revenue | ★ $66,218,999.00 | N/A |
| Revenue This Year | $14.63 | N/A |
| Revenue Next Year | $11.54 | N/A |
| P/E Ratio | $30.97 | ★ N/A |
| Revenue Growth | ★ 16.05 | N/A |
| 52 Week Low | $17.73 | $1.99 |
| 52 Week High | $35.56 | $8.54 |
Technical Indicators
Market Signals| Indicator | ELMD | GNLX |
|---|---|---|
| Relative Strength Index (RSI) | 58.68 | 41.11 |
| Support Level | $28.12 | $4.21 |
| Resistance Level | $29.44 | $4.46 |
| Average True Range (ATR) | 1.28 | 0.25 |
| MACD | -0.16 | 0.06 |
| Stochastic Oscillator | 61.54 | 46.90 |
Price Performance
Historical ComparisonAbout ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.